Gene Review:
HTR1D - 5-hydroxytryptamine (serotonin) receptor...
Homo sapiens
Synonyms:
5-HT-1D, 5-HT-1D-alpha, 5-HT1D, 5-hydroxytryptamine receptor 1D, HT1DA, ...
- Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries. Hamel, E., Fan, E., Linville, D., Ting, V., Villemure, J.G., Chia, L.S. Mol. Pharmacol. (1993)
- The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine. Petty, M.A., Elands, J., Johnson, M.P., Linnik, M.D., Hamel, E., Moskowitz, M.A., Lee, W.S., McCarty, D.R., Hibert, M., Baron, B.M. Eur. J. Pharmacol. (1997)
- Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache. Rainero, I., Valfrè, W., Savi, L., Ferrero, M., Del Rizzo, P., Limone, P., Isaia, G.C., Gianotti, L., Pollo, A., Verde, R., Benedetti, F., Pinessi, L. Headache. (2002)
- Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses? Montgomery, S.A., Fineberg, N. The British journal of psychiatry. Supplement. (1989)
- Psychoactivity and abuse potential of sumatriptan. Sullivan, J.T., Preston, K.L., Testa, M.P., Busch, M., Jasinski, D.R. Clin. Pharmacol. Ther. (1992)
- Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Bergen, A.W., van den Bree, M.B., Yeager, M., Welch, R., Ganjei, J.K., Haque, K., Bacanu, S., Berrettini, W.H., Grice, D.E., Goldman, D., Bulik, C.M., Klump, K., Fichter, M., Halmi, K., Kaplan, A., Strober, M., Treasure, J., Woodside, B., Kaye, W.H. Mol. Psychiatry (2003)
- Functional behavioral homology between rat 5-HT1B and guinea pig 5-HT1D receptors in the modulation of prepulse inhibition of startle. Sipes, T.E., Geyer, M.A. Psychopharmacology (Berl.) (1996)
- The genes encoding the 5HT1D alpha and 5HT1D beta receptors are unchanged in patients with panic disorder. Ohara, K., Xie, D.W., Ishigaki, T., Deng, Z.L., Nakamura, Y., Suzuki, Y., Miyasato, K., Ohara, K. Biol. Psychiatry (1996)
- Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: effects of light therapy. Yatham, L.N., Lam, R.W., Zis, A.P. Biol. Psychiatry (1997)
- Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Arranz, B., Eriksson, A., Mellerup, E., Plenge, P., Marcusson, J. Biol. Psychiatry (1994)
- Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents. Peroutka, S.J. Pharmacol. Rev. (1991)
- Treatment of acute migraine with subcutaneous sumatriptan. Cady, R.K., Wendt, J.K., Kirchner, J.R., Sargent, J.D., Rothrock, J.F., Skaggs, H. JAMA (1991)
- Migraine: a research field matured for the basic neurosciences. Olesen, J., Edvinsson, L. Trends Neurosci. (1991)
- Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Hartig, P.R., Hoyer, D., Humphrey, P.P., Martin, G.R. Trends Pharmacol. Sci. (1996)
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Moskowitz, M.A. Trends Pharmacol. Sci. (1992)
- Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Lesage, A.S., Wouters, R., Van Gompel, P., Heylen, L., Vanhoenacker, P., Haegeman, G., Luyten, W.H., Leysen, J.E. Br. J. Pharmacol. (1998)
- Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. Goldberg, M.R., Lee, Y., Vyas, K.P., Slaughter, D.E., Panebianco, D., Ermlich, S.J., Shadle, C.R., Brucker, M.J., McLoughlin, D.A., Olah, T.V. Journal of clinical pharmacology. (2000)
- Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Napier, C., Stewart, M., Melrose, H., Hopkins, B., McHarg, A., Wallis, R. Eur. J. Pharmacol. (1999)
- 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study. Visser, W.H., Klein, K.B., Cox, R.C., Jones, D., Ferrari, M.D. Neurology (1996)
- Differences in gene density on chicken macrochromosomes and microchromosomes. Smith, J., Bruley, C.K., Paton, I.R., Dunn, I., Jones, C.T., Windsor, D., Morrice, D.R., Law, A.S., Masabanda, J., Sazanov, A., Waddington, D., Fries, R., Burt, D.W. Anim. Genet. (2000)
- Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta. Weinshank, R.L., Zgombick, J.M., Macchi, M.J., Branchek, T.A., Hartig, P.R. Proc. Natl. Acad. Sci. U.S.A. (1992)
- Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Hamblin, M.W., Metcalf, M.A. Mol. Pharmacol. (1991)
- Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1D receptors. Fink, K., Zentner, J., Göthert, M. Naunyn Schmiedebergs Arch. Pharmacol. (1995)
- Serotonin 5-HT1D receptors. Hoyer, D., Schoeffter, P., Waeber, C., Palacios, J.M. Ann. N. Y. Acad. Sci. (1990)
- Further Evidence of Association of OPRD1 & HTR1D Polymorphisms with Susceptibility to Anorexia Nervosa. Brown, K.M., Bujac, S.R., Mann, E.T., Campbell, D.A., Stubbins, M.J., Blundell, J.E. Biol. Psychiatry (2007)
- 5-HT 1B/D receptor antagonists. Pauwels, P.J. Gen. Pharmacol. (1997)
- Conversion of the human 5-HT1D beta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis. Metcalf, M.A., McGuffin, R.W., Hamblin, M.W. Biochem. Pharmacol. (1992)
- Identification of 5-hydroxytryptamine1D binding sites in sheep caudate nucleus membranes. Pauwels, P.J., Palmier, C., Briley, M. Biochem. Pharmacol. (1993)
- Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors. Kaumann, A.J., Frenken, M., Posival, H., Brown, A.M. Circulation (1994)
- Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Silberstein, S.D., McCrory, D.C. Headache. (2003)
- 5-HT in nervous system disease and migraine. Fozard, J.R., Kalkman, H.O. Current opinion in neurology and neurosurgery. (1992)
- Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Libert, F., Passage, E., Parmentier, M., Simons, M.J., Vassart, G., Mattei, M.G. Genomics (1991)
- 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Verheggen, R., Hundeshagen, A.G., Brown, A.M., Schindler, M., Kaumann, A.J. Br. J. Pharmacol. (1998)
- The biology of serotonin receptors: focus on migraine pathophysiology and treatment. Hamel, E. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. (1999)
- New targets in the acute treatment of headache. Goadsby, P.J. Curr. Opin. Neurol. (2005)
- Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity. Hamblin, M.W., Metcalf, M.A., McGuffin, R.W., Karpells, S. Biochem. Biophys. Res. Commun. (1992)
- Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Rebeck, G.W., Maynard, K.I., Hyman, B.T., Moskowitz, M.A. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands). Pregenzer, J.F., Alberts, G.L., Im, W.B., Slightom, J.L., Ennis, M.D., Hoffman, R.L., Ghazal, N.B., TenBrink, R.E. Br. J. Pharmacol. (1999)